
Addiction and Mental Health Conditions

When someone comes into detox at Turning Point Recovery Center—especially for opioids—there’s a question that almost always shows up sooner or later:
“After this… am I going to be totally sober with no medications,
or am I going to be on something like Suboxone or Brixadi?”
Sometimes people whisper it. Sometimes they lead with it. Sometimes a family member asks first, half-expecting judgment no matter which way they lean.
The truth is: both paths—full abstinence and medication-assisted treatment—can be valid, evidence-based ways to recover. The hard part is figuring out which one makes sense for you right now.
Organizations like the National Institutes of Health (NIH) and the National Institute on Drug Abuse (NIDA) describe addiction as a chronic brain disease that changes how reward, stress, and self-control systems function—not a simple issue of willpower. That’s why the decision about abstinence versus Suboxone/Brixadi isn’t a moral quiz; it’s a clinical and practical conversation.
This article isn’t about declaring a winner. It’s about showing you how we walk through the decision together at Turning Point.
We’ve seen people build strong, meaningful lives in abstinence-based recovery. We’ve also seen people’s lives literally saved by medications for opioid use disorder (MOUD)—treatments like buprenorphine (Suboxone and injectable formulations like Brixadi), methadone, and extended-release naltrexone.
The U.S. Food and Drug Administration highlights that these medications are safe and effective and form the backbone of evidence-based treatment for opioid use disorder. NIDA and other NIH-backed resources say the same: MOUD reduces overdose risk and improves treatment retention.
On one side you have:
On the other side you have:
So when we talk about abstinence vs Suboxone/Brixadi, we’re not debating philosophy in a vacuum. We’re looking at your life and your risk in the context of what national science organizations already know.
At Turning Point, this conversation usually begins in detox, once you’re medically stable enough to think and talk clearly.
Our addictionologist medical director and clinical team don’t start with a lecture. We start with questions:
From there, we lay out both paths in plain language and connect them to what the research actually says.
Guidelines like the ASAM National Practice Guideline for the Treatment of Opioid Use Disorder emphasize individualized decisions about medications, based on severity, risk, and patient preferences—not blanket “always” or “never” rules.
For some people, abstinence resonates deeply because:
But to keep that path honest and safe, we also talk about the realities:
When we talk about abstinence, we don’t sugarcoat it or dismiss it. We walk through what it would actually require in your life—your home, your job, your legal situation, your mental health—to make abstinence both possible and reasonably safe.
Medications like Suboxone (buprenorphine/naloxone) and extended-release buprenorphine injections (like Brixadi) are used as medications for opioid use disorder (MOUD).
The goal, as summarized in guides from SAMHSA and NIDA, is to:
For many people, a MOUD plan feels like a huge relief:
We also talk through the very real concerns:
The ASAM OUD guideline and FDA MOUD resources make it clear: there is no single “right” length of treatment. Some people benefit from years of maintenance; others taper off after they have strong supports in place.
At Turning Point, we don’t use medications as a shortcut or a crutch—but we also don’t ignore the data that says MOUD can cut mortality risk and keep people in treatment longer.
One of the most common fears we hear is:
“If I start Suboxone or Brixadi, I’m signing up for this for life.”
That’s not how we see it.
We talk about medications in phases:
Some people stay on MOUD for years and do very well. Others taper down carefully once cravings, stressors, and environment are much more manageable. Clinical reviews and primary-care guidance—like those from the American Academy of Family Physicians—show that staying on medication long enough greatly improves the chance of sustained recovery.
The same flexibility applies to abstinence. Someone might start abstinent and later decide to add medication if cravings become overwhelming or life circumstances change. That’s not failure—that’s adjusting the plan to protect your life.
When we’re helping you weigh abstinence vs Suboxone/Brixadi, we look at things like:
We also talk honestly about your gut sense:
We’re guided not only by medical evidence, but also by ethics. The NAADAC Code of Ethics describes addiction professionals’ responsibility to provide client-centered, culturally sensitive, evidence-based care and to respect client autonomy. That’s the stance we take in this decision-making process.
Whatever direction you lean—abstinence or MOUD—you’re not doing it alone, and you’re not just getting a prescription or a pat on the back.
At Turning Point in Albuquerque, we wrap that choice in a full continuum of care:
Our clinical practices are aligned with national standards from SAMHSA, ASAM, NIDA, and the ethical expectations summarized in NAADAC’s code.
You don’t have to decide this in isolation, and you don’t have to make a lifetime promise today.
If you’re in or near Albuquerque and you’re wondering whether abstinence or a Suboxone/Brixadi plan makes more sense for you:
The goal isn’t to win an argument about which philosophy is “right.” The goal is for you to stay alive, get better, and build a life you actually want to keep.
